purif character inhibitor solubl tumor necrosi factor receptor tumor necrosi factor lymphotoxin serum ultrafiltr human cancer patient serum suf human patient differ type cancer block factor BF cytolyt activ human tumor necrosi factor alpha tnf-alpha vitro BF protein molecular mass kda sodium dodecyl sulfate/polyacrylamid gel electrophoresi sds/page activ materi homogen combin affin chromatographi page high-pressur liquid chromatographi amino acid sequenc analysi BF membran tnf receptor purifi BF lytic activ recombin human tnf-alpha recombin human lymphotoxin murin cell vitro BF lytic activ tnf-alpha lymphotoxin BF necrot activ recombin human tnf-alpha cutan meth tumor balb/c mice BF import role regul control tnf-alpha lymphotoxin activ cancer patient ii interact tumor host antitumor mechan iii use tnf-alpha clinic trial human cancer patient 